| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.26 | 6e-08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |